Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1621 AL 1635

The Neuroprotective Role of Tangeritin

Fatima J, Siddique YH.

CNS Neurol Disord Drug Targets. 2025;24(2):144-157. doi: 10.2174/0118715273325789240904065214.

Confirmation of RAB32 Ser71Arg Involvement in Parkinson's Disease

Cogan G, Tesson C, Brefel-Courbon C, Lanore A, Kodjovi GC, Welment L, Clot F, Lesage S, Brice A.

Mov Disord. 2025 Jan;40(1):174-175. doi: 10.1002/mds.30024. Epub 2024 Sep 23.

Unlocking Hope: Therapeutic Advances and Approaches in Modulating the Wnt Pathway for Neurodegenerative Diseases

Faraji N, Ebadpour N, Abavisani M, Gorji A.

Mol Neurobiol. 2025 Mar;62(3):3630-3652. doi: 10.1007/s12035-024-04462-4. Epub 2024 Sep 23.

Velocity-Based-Training Frequency Impacts Changes in Muscle Morphology, Neuromuscular Performance, and Functional Capability in Persons With Parkinson's Disease

Calaway C, Walls K, Levitt H, Caplan J, Mann B, Martinez K, Gastaldo R, Haq I, Signorile JF.

J Strength Cond Res. 2025 Jan 1;39(1):99-106. doi: 10.1519/JSC.0000000000004951. Epub 2024 Sep 24.

Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements

Nayak U, Halagali P, Panchal KN, Tippavajhala VK, Mudgal J, Radhakrishnan R, Manikkath J.

Curr Pharm Des. 2025;31(6):443-460. doi: 10.2174/0113816128328722240828184410.

TMS and tDCS as potential tools for the treatment of cognitive deficits in Parkinson's disease: a meta-analysis

Giustiniani A, Maistrello L, Mologni V, Danesin L, Burgio F.

Neurol Sci. 2025 Feb;46(2):579-592. doi: 10.1007/s10072-024-07778-0. Epub 2024 Sep 25.

The Multifaceted Role of L-Type Amino Acid Transporter 1 at the Blood-Brain Barrier: Structural Implications and Therapeutic Potential

Ahmed HS.

Mol Neurobiol. 2025 Mar;62(3):3813-3832. doi: 10.1007/s12035-024-04506-9. Epub 2024 Sep 26.

Exploring the Neuroprotective Potential of Icariin through Modulation of Neural Pathways in the Treatment of Neurological Diseases

Sharma S, Mehan S, Khan Z, Tiwari A, Kumar A, Gupta GD, Narula AS, Kalfin R.

Curr Mol Med. 2025;25(8):962-979. doi: 10.2174/0115665240317650240924041923.

Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations

Pocora MM, Avenali M, Croce MG, Ferrari F, Valentino F, Pacchetti C, Tassorelli C, Zangaglia R.

Mov Disord Clin Pract. 2025 Jan;12(1):115-117. doi: 10.1002/mdc3.14216. Epub 2024 Sep 27.

Molecular Alterations in Core Subunits of Mitochondrial Complex I and Their Relation to Parkinson's Disease

Epifane-de-Assunção MC, Bispo AG, Ribeiro-Dos-Santos Â, Cavalcante GC.

Mol Neurobiol. 2025 Jun;62(6):6968-6982. doi: 10.1007/s12035-024-04526-5. Epub 2024 Sep 27.

Effects of long-term Tai Chi vs. aerobic exercise on antioxidant activity and cognitive function in individuals with Parkinson's disease

Tsai CL, Chien CY, Pan CY, Tseng YT, Wang TC, Lin TK.

Behav Brain Res. 2025 Jan 5;476:115274. doi: 10.1016/j.bbr.2024.115274. Epub 2024 Sep 25.

Nasojejunal Tube Placement for Levodopa-carbidopa Intestinal Gel Treatment by Neurologists in Patients with Advanced Parkinson's Disease: A Retrospective Observational Study

Ueno T, Haga R, Utsugisawa T, Horiuchi M, Miura M, Kinoshita I, Nakamura T, Arai A, Tomiyama M.

Intern Med. 2025 May 1;64(9):1315-1320. doi: 10.2169/internalmedicine.4394-24. Epub 2024 Sep 27.

Cross-expression meta-analysis of 695 brain samples reveals coordinated gene expression across spatially adjacent cells

Sarwar A, Rue M, French L, Cross H, Choi S, Chen X, Gillis J.

bioRxiv [Preprint]. 2025 May 18:2024.09.17.613579. doi: 10.1101/2024.09.17.613579.

Structural Insights and Biological Activities of Furan-Based Drugs in the Treatment of Human Diseases

Mishra AK, Singh K, Saha S, Bharadwaj H, Gupta JK, Shah K, Kumar S, Jain D, Verma H.

Comb Chem High Throughput Screen. 2025;28(16):2781-2793. doi: 10.2174/0113862073319757240912055303.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias